Recruiting Myelodysplastic Syndromes Studies in Burlington
About Myelodysplastic Syndromes Clinical Trials in Burlington
Myelodysplastic syndromes (MDS) are a group of cancers in which immature blood cells in the bone marrow do not mature properly. MDS can progress to acute myeloid leukemia. Treatments include growth factors, chemotherapy, and stem cell transplant.
There are currently 1 myelodysplastic syndromes clinical trials recruiting participants in Burlington, NC. These studies are seeking a combined 30 participants. Research is being sponsored by University of Vermont. Clinical trial participation is free and participants receive study-related medical care at no cost.
Myelodysplastic Syndromes Clinical Trials in Burlington — FAQ
Are there myelodysplastic syndromes clinical trials in Burlington?
Yes, there are 1 myelodysplastic syndromes clinical trials currently recruiting in Burlington, NC. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Burlington?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Burlington research site will contact you about next steps.
Are clinical trials in Burlington free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Burlington studies also compensate for your time and travel.
What myelodysplastic syndromes treatments are being tested?
The 1 active trials in Burlington are testing new therapies including novel drugs, biologics, and treatment approaches for myelodysplastic syndromes.
Data updated July 13, 2026 from ClinicalTrials.gov